• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MAP Pharmaceuticals Inc


Ticker Delisted

Snapshot for MAP Pharmaceuticals Inc (3M3)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for 3M3

No chart data available.
  • 3M3:GR
  • 1M
  • 1Y
Interactive 3M3 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3M3

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 37.5661
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 0.6180
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3M3

No data available

Company Profile & Key Executives for 3M3

MAP Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops treatments for respiratory and CNS diseases.

Thomas A ArmerChief Scientific Ofcr/FounderChristopher Y ChaiSenior VP/CFO
Charlene Andros FriedmanSenior VP/Secretary/Gen CnslScott W BorlandSenior VP:Neurology Franchise
More Company Profile & Key Executives for 3M3

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil